Analyst consensus rating
Vicore Pharma Holding Analyst Rating: none
Direct answer
Vicore Pharma Holding's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $34.57.
Forecast evidence checked September 9, 2026.
Get free Vicore Pharma Holding email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.89
- Average price target
- $34.57
- High price target
- $34.57
- Low price target
- $34.57
- Low target gap
- +190.7%
- Target upside
- +190.7%
- High target gap
- +190.7%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- September 9, 2026
- Valid through
- September 16, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vicore Pharma Holding?
Vicore Pharma Holding has a verified none consensus. The same dataset has an average price target of $34.57.
How far are Vicore Pharma Holding's low and high targets from the recorded price?
The low target implies +190.7%, while the high target implies +190.7%.
How many analysts are included in Vicore Pharma Holding's consensus?
The verified consensus includes 1 analysts.
How is Vicore Pharma Holding's target upside or downside calculated?
The average target of $34.57 is divided by the recorded price of $11.89, then one is subtracted to produce +190.7%. This does not guarantee a future return.
When was Vicore Pharma Holding's analyst forecast verified?
The data was verified on 2026-09-09. The dataset is valid through 2026-09-16.